【レポートの概要（一部）】
Executive Summary
Section 1: Analyzing the Global Pharmaceutical Industry
A. Historical Perspective of the Global Pharmaceutical Industry
B. Analysis of the Global Pharmaceutical Industry
B.1 Industry Definitions
B.1.1 Pharmaceutical Industry
B.1.2 Bulk Drugs
B.1.3 Formulations
B.2 Industry Statistics
B.3 Industry Value Analysis
B.4 Market Segments
B.5 Market Share Analysis
B.6 Competition in the Industry
B.7 Market Forecast
C. Global Pharmaceutical Industry: Porter’s Five Forces Strategy Analysis
C.1 Introduction
C.2 Bargaining Power of Buyers
C.3 Bargaining Power of Suppliers
C.4 Competitive Rivalry in the Industry
C.5 Threat of New Entrants
C.6 Threat of Substitutes
D. Analysis of the Global OTC Pharmaceutical Industry
D.1 Industry Definition
D.2 Industry Statistics
D.3 Industry Value Analysis
D.4 Market Segments
D.5 Distribution Channels
D.6 Market Share Analysis
D.7 Market Forecast
E. Global OTC Pharmaceutical Industry: Porter’s Five Forces Strategy Analysis
E.1 Introduction
E.2 Bargaining Power of Buyers
E.3 Bargaining Power of Suppliers
E.4 Competitive Rivalry in the Industry
E.5 Threat of New Entrants
E.6 Threat of Substitutes
F. Analysis the Global Generics Industry
F.1 Industry Definition
F.2 Industry Statistics
F.3 Industry Value & Volume Analysis
F.4 Market Segments
F.5 Industry Structure
F.6 Patent Expiries
F.7 Patent Expiries by Therapeutic Areas
F.8 Research & Development in the Industry
F.8.1 Super Generics
F.8.2 Biosimilars
F.9 Market Forecast
G. Global Generics Industry: Porter’s Five Forces Strategy Analysis
G.1 Introduction
G.2 Bargaining Power of Buyers
G.3 Bargaining Power of Suppliers
G.4 Competitive Rivalry in the Industry
G.5 Threat of New Entrants
G.6 Threat of Substitutes
H. Structure of the Global Pharmaceutical Industry
H.1 R&D Pipelines
H.2 Defense against Generic Competition
H.3 Looking at Restructuring and Outsourcing
H.4 Strategic Alliances
I. Analyzing the Industry
I.1 Barriers to Entry
I.2 Lifecycle of a Drug
I.2.1 The Patent System
I.2.2 Drug Lifecycle
I.3 Industry Cost Structure
I.3.1 Types of Costs
I.3.2 Evidence on Cost Structure
I.3.3 Increasing Costs & Risks of Developing New Drugs
I.3.4 Conclusion
I.4 Trends in the Global Pharmaceutical Industry
I.5 Business Environment
I.6 Industry Innovation
I.7 Globalization of the Pharmaceutical Industry
I.8 Role of Genomics
J. Factors Driving Growth & Change in the Global Pharmaceutical Industry
J.1 Introduction
J.2 Growth in the Pharma Market
J.3 Reasons for Growth
J.4 New Product Lines
J.5 Opportunities in CNS Disorders & Oncology Research
J.6 Commercialization of Dormant Compounds
J.7 Generic/Biosimilar Versions of Biologics
K. Challenges Facing the Global Pharmaceutical Industry
K.1 Parallel Trade
K.2 Rising Cost of Healthcare
K.3 Immense Pressure on Industry Revenues
K.4 Uncertainty in Pipeline
K.5 Increasing Risks
K.6 Issues with Outcome-based Pricing
N. Offshoring in the Pharmaceutical Sector
N.1 Introduction
N.1.1 What is Offshoring?
N.1.2 Analyzing the Pharma Value Chain
N.1.3 Employment Scenario of the Pharmaceutical Industry
N.1.4 Why Offshore?
N.1.5 Primary Offshoring Locations
N.2 Offshoring of R&D
N.2.1 India
N.2.2 China
N.2.3 Growth Factors
N.2.4 Challenges & Barriers to Offshoring R&D
N.3 Offshoring of Pharmaceutical Manufacturing Processes
N.3.1 Overview
N.3.2 Biologics Manufacturing
N.3.3 API Manufacturing
N.3.4 Final Dosage Manufacturing
N.3.5 Growth Factors
N.3.6 Challenges & Barriers to Offshoring Manufacturing Processes
Section 2: Analyzing the Global Pharmaceutical Markets
A. Pharmaceutical Industry in Australia
A.1 Industry Statistics
A.2 Industry Value Analysis
A.3 Geographic Segmentation
A.4 Industry Trends
A.5 Production Trends
A.6 Market Share Analysis
A.7 Competition in the Industry
A.8 Industry Outlook
B. Pharmaceutical Industry in Belgium
B.1 Industry Statistics
B.2 Industry Value Analysis
B.3 Geographic Segmentation
B.4 Market Share Analysis
B.5 Competition in the Industry
B.6 Industry Outlook
C. Pharmaceutical Industry in Brazil
C.1 Industry Statistics
C.2 Industry Value Analysis
C.3 Geographic Segmentation
C.4 Market Share Analysis
C.5 Competition in the Industry
C.6 Industry Outlook
D. Pharmaceutical Industry in Canada
D.1 Industry Statistics
D.2 Industry Value Analysis
D.3 Geographic Segmentation
D.4 Market Share Analysis
D.5 Competition in the Industry
D.6 Industry Outlook
E. Pharmaceutical Industry in China
E.1 Industry Statistics
E.2 Industry Value Analysis
E.3 Geographic Segmentation
E.4 Industry Trends
E.5 Production Trends
E.6 Regulatory Framework
E.7 Market for Traditional Chinese Medicine
E.8 Market Share Analysis
E.9 Competition in the Industry
E.10 Industry Outlook
F. Pharmaceutical Industry in Czech Republic
F.1 Industry Statistics
F.2 Industry Value Analysis
F.3 Geographic Segmentation
F.4 Market Share Analysis
F.5 Competition in the Industry
F.6 Industry Outlook
G. Pharmaceutical Industry in Denmark
G.1 Industry Statistics
G.2 Industry Value Analysis
G.3 Geographic Segmentation
G.4 Market Share Analysis
G.5 Competition in the Industry
G.6 Industry Outlook
H. Pharmaceutical Industry in France
H.1 Industry Statistics
H.2 Industry Value Analysis
H.3 Geographic Segmentation
H.4 Market Share Analysis
H.5 Competition in the Industry
H.6 Industry Outlook
I. Pharmaceutical Industry in Germany
I.1 Industry Statistics
I.2 Industry Value Analysis
I.3 Geographic Segmentation
I.4 Market Share Analysis
I.5 Competition in the Industry
I.6 Industry Outlook
J. Pharmaceutical Industry in Hungary
J.1 Industry Statistics
J.2 Industry Value Analysis
J.3 Geographic Segmentation
J.4 Market Share Analysis
J.5 Competition in the Industry
J.6 Industry Outlook
K. Pharmaceutical Industry in India
K.1 Industry Statistics
K.2 Industry Value Analysis
K.3 Geographic Segmentation
K.4 Industry Trends
K.5 Production Trends
K.6 Market Share Analysis
K.7 Competition in the Industry
K.8 Industry Outlook
L. Pharmaceutical Industry in Italy
L.1 Industry Statistics
L.2 Industry Value Analysis
L.3 Geographic Segmentation
L.4 Market Share Analysis
L.5 Competition in the Industry
L.6 Industry Outlook
M. Pharmaceutical Industry in Japan
M.1 Industry Statistics
M.2 Industry Value Analysis
M.3 Geographic Segmentation
M.4 Industry Trends
M.5 Production Trends
M.6 Market Share Analysis
M.7 Competition in the Industry
M.8 Industry Outlook
N. Pharmaceutical Industry in Mexico
N.1 Industry Statistics
N.2 Industry Value Analysis
N.3 Geographic Segmentation
N.4 Market Share Analysis
N.5 Competition in the Industry
N.6 Industry Outlook
O. Pharmaceutical Industry in Netherlands
O.1 Industry Statistics
O.2 Industry Value Analysis
O.3 Geographic Segmentation
O.4 Market Share Analysis
O.5 Competition in the Industry
O.6 Industry Outlook
P. Pharmaceutical Industry in New Zealand
P.1 Industry Statistics
P.2 Industry Value Analysis
P.3 Geographic Segmentation
P.4 Market Share Analysis
P.5 Competition in the Industry
P.6 Industry Outlook
Q. Pharmaceutical Industry in Norway
Q.1 Industry Statistics
Q.2 Industry Value Analysis
Q.3 Geographic Segmentation
Q.4 Market Share Analysis
Q.5 Competition in the Industry
Q.6 Industry Outlook
R. Pharmaceutical Industry in Poland
R.1 Industry Statistics
R.2 Industry Value Analysis
R.3 Geographic Segmentation
R.4 Market Share Analysis
R.5 Competition in the Industry
R.6 Industry Outlook
S. Pharmaceutical Industry in Russia
S.1 Industry Statistics
S.2 Industry Value Analysis
S.3 Geographic Segmentation
S.4 Market Share Analysis
S.5 Competition in the Industry
S.6 Industry Outlook
T. Pharmaceutical Industry in Singapore
T.1 Industry Statistics
T.2 Industry Value Analysis
T.3 Geographic Segmentation
T.4 Market Share Analysis
T.5 Competition in the Industry
T.6 Industry Outlook
U. Pharmaceutical Industry in South Africa
U.1 Industry Statistics
U.2 Industry Value Analysis
U.3 Geographic Segmentation
U.4 Market Share Analysis
U.5 Competition in the Industry
U.6 Industry Outlook
V. Pharmaceutical Industry in South Korea
V.1 Industry Statistics
V.2 Industry Value Analysis
V.3 Geographic Segmentation
V.4 Market Share Analysis
V.5 Competition in the Industry
V.6 Industry Outlook
W. Pharmaceutical Industry in Spain
W.1 Industry Statistics
W.2 Industry Value Analysis
W.3 Geographic Segmentation
W.4 Market Share Analysis
W.5 Competition in the Industry
W.6 Industry Outlook
X. Pharmaceutical Industry in Sweden
X.1 Industry Statistics
X.2 Industry Value Analysis
X.3 Geographic Segmentation
X.4 Market Share Analysis
X.5 Competition in the Industry
X.6 Industry Outlook
Y. Pharmaceutical Industry in Taiwan
Y.1 Industry Statistics
Y.2 Industry Value Analysis
Y.3 Geographic Segmentation
Y.4 Market Share Analysis
Y.5 Competition in the Industry
Y.6 Industry Outlook
Z. Pharmaceutical Industry in United Kingdom
Z.1 Industry Statistics
Z.2 Industry Value Analysis
Z.3 Geographic Segmentation
Z.4 Market Share Analysis
Z.5 Competition in the Industry
Z.6 Industry Outlook
AA. Pharmaceutical Industry in the United States
AA.1 Industry Statistics
AA.2 Industry Value Analysis
AA.3 Geographic Segmentation
AA.4 Market Share Analysis
AA.5 Competition in the Industry
AA.6 Industry Outlook
Section 3: Analyzing the Major Market Players
A. Abbott Laboratories
A.1 Corporate Profile
A.2 Business Segment Analysis
A.3 Financial Analysis
A.4 Ratio Analysis
A.5 Major Products & Services
A.6 SWOT Analysis
B. Allergan, Inc.
B.1 Corporate Profile
B.2 Business Segment Analysis
B.3 Financial Analysis
B.4 Ratio Analysis
B.5 Major Products & Services
B.6 SWOT Analysis
C. Amgen, Inc.
C.1 Corporate Profile
C.2 Business Segment Analysis
C.3 Financial Analysis
C.4 Ratio Analysis
C.5 Major Products & Services
C.6 SWOT Analysis
D. Apotex, Inc.
D.1 Corporate Profile
D.2 Business Segment Analysis
D.3 Financial Analysis
D.4 Ratio Analysis
D.5 Major Products & Services
D.6 SWOT Analysis
E. Aspen Pharmacare Holdings Limited
E.1 Corporate Profile
E.2 Business Segment Analysis
E.3 Financial Analysis
E.4 Ratio Analysis
E.5 Major Products & Services
E.6 SWOT Analysis
F. Astellas Pharma
F.1 Corporate Profile
F.2 Business Segment Analysis
F.3 Financial Analysis
F.4 Ratio Analysis
F.5 Major Products & Services
F.6 SWOT Analysis
G. AstraZeneca
G.1 Corporate Profile
G.2 Business Segment Analysis
G.3 Financial Analysis
G.4 Ratio Analysis
G.5 Major Products & Services
G.6 SWOT Analysis
H. Baxter International
H.1 Corporate Profile
H.2 Business Segment Analysis
H.3 Financial Analysis
H.4 Ratio Analysis
H.5 Major Products & Services
H.6 SWOT Analysis
I. Bayer AG
I.1 Corporate Profile
I.2 Business Segment Analysis
I.3 Financial Analysis
I.4 Ratio Analysis
I.5 Major Products & Services
I.6 SWOT Analysis
J. Boehringer Ingelheim
J.1 Corporate Profile
J.2 Business Segment Analysis
J.3 Financial Analysis
J.4 Ratio Analysis
J.5 Major Products & Services
J.6 SWOT Analysis
K. Bristol-Myers Squibb
K.1 Corporate Profile
K.2 Business Segment Analysis
K.3 Financial Analysis
K.4 Ratio Analysis
K.5 Major Products & Services
K.6 SWOT Analysis
L. Chugai Pharmaceutical
L.1 Corporate Profile
L.2 Business Segment Analysis
L.3 Financial Analysis
L.4 Ratio Analysis
L.5 Major Products & Services
L.6 SWOT Analysis
M. Daewoong Pharmaceutical Co Ltd.
M.1 Corporate Profile
M.2 Business Segment Analysis
M.3 Financial Analysis
M.4 Ratio Analysis
M.5 Major Products & Services
M.6 SWOT Analysis
N. Daiichi Sankyo Company
N.1 Corporate Profile
N.2 Business Segment Analysis
N.3 Financial Analysis
N.4 Ratio Analysis
N.5 Major Products & Services
N.6 SWOT Analysis
O. Eisai Co., Ltd
O.1 Corporate Profile
O.2 Business Segment Analysis
O.3 Financial Analysis
O.4 Ratio Analysis
O.5 Major Products & Services
O.6 SWOT Analysis
P. Eli Lilly and Company
P.1 Corporate Profile
P.2 Business Segment Analysis
P.3 Financial Analysis
P.4 Ratio Analysis
P.5 Major Products & Services
P.6 SWOT Analysis
Q. F. Hoffmann-La Roche
Q.1 Corporate Profile
Q.2 Business Segment Analysis
Q.3 Financial Analysis
Q.4 Ratio Analysis
Q.5 Major Products & Services
Q.6 SWOT Analysis
R. GlaxoSmithKline Plc
R.1 Corporate Profile
R.2 Business Segment Analysis
R.3 Financial Analysis
R.4 Ratio Analysis
R.5 Major Products & Services
R.6 SWOT Analysis
S. Johnson & Johnson
S.1 Corporate Profile
S.2 Business Segment Analysis
S.3 Financial Analysis
S.4 Ratio Analysis
S.5 Major Products & Services
S.6 SWOT Analysis
T. Lupin Limited
T.1 Corporate Profile
T.2 Business Segment Analysis
T.3 Financial Analysis
T.4 Ratio Analysis
T.5 Major Products & Services
T.6 SWOT Analysis
U. Merck & Co.
U.1 Corporate Profile
U.2 Business Segment Analysis
U.3 Financial Analysis
U.4 Ratio Analysis
U.5 Major Products & Services
U.6 SWOT Analysis
V. Novartis AG
V.1 Corporate Profile
V.2 Business Segment Analysis
V.3 Financial Analysis
V.4 Ratio Analysis
V.5 Major Products & Services
V.6 SWOT Analysis
W. Pfizer
W.1 Corporate Profile
W.2 Business Segment Analysis
W.3 Financial Analysis
W.4 Ratio Analysis
W.5 Major Products & Services
W.6 SWOT Analysis
X. Richter Gedeon Vegyeszeti Gyar Nyrt
X.1 Corporate Profile
X.2 Business Segment Analysis
X.3 Financial Analysis
X.4 Ratio Analysis
X.5 Major Products & Services
X.6 SWOT Analysis
Y. Sanofi SA
Y.1 Corporate Profile
Y.2 Business Segment Analysis
Y.3 Financial Analysis
Y.4 Ratio Analysis
Y.5 Major Products & Services
Y.6 SWOT Analysis
Z. Shanghai Pharmaceuticals Holding Co. Ltd.
Z.1 Corporate Profile
Z.2 Business Segment Analysis
Z.3 Financial Analysis
Z.4 Ratio Analysis
Z.5 Major Products & Services
Z.6 SWOT Analysis
AA. Sumitomo Dainippon Pharma
AA.1 Corporate Profile
AA.2 Business Segment Analysis
AA.3 Financial Analysis
AA.4 Ratio Analysis
AA.5 Major Products & Services
AA.6 SWOT Analysis
BB. Takeda Pharmaceutical Company Limited
BB.1 Corporate Profile
BB.2 Business Segment Analysis
BB.3 Financial Analysis
BB.4 Ratio Analysis
BB.5 Major Products & Services
BB.6 SWOT Analysis
CC. Teva Pharmaceutical Industries
CC.1 Corporate Profile
CC.2 Business Segment Analysis
CC.3 Financial Analysis
CC.4 Ratio Analysis
CC.5 Major Products & Services
CC.6 SWOT Analysis
DD. Aurobindo Pharma Ltd
DD.1 Corporate Profile
DD.2 Business Segment Analysis
DD.3 Financial Analysis
DD.4 Ratio Analysis
DD.5 Major Products & Services
EE. Cadila Healthcare
EE.1 Corporate Profile
EE.2 Business Segment Analysis
EE.3 Financial Analysis
EE.4 Ratio Analysis
EE.5 Major Products & Services
FF. China National Accord Medicines Corporation Ltd
FF.1 Corporate Profile
FF.2 Business Segment Analysis
FF.3 Financial Analysis
FF.4 Ratio Analysis
FF.5 Major Products & Services
GG. Cipla Ltd
GG.1 Corporate Profile
GG.2 Business Segment Analysis
GG.3 Financial Analysis
GG.4 Ratio Analysis
GG.5 Major Products & Services
HH. Dr. Reddy’s Laboratories Limited
HH.1 Corporate Profile
HH.2 Business Segment Analysis
HH.3 Financial Analysis
HH.4 Ratio Analysis
HH.5 Major Products & Services
II. Hanmi Science Co Ltd
II.1 Corporate Profile
II.2 Business Segment Analysis
II.3 Financial Analysis
II.4 Ratio Analysis
II.5 Major Products & Services
JJ. Harbin Pharmaceutical Group Co. Ltd.
JJ.1 Corporate Profile
JJ.2 Business Segment Analysis
JJ.3 Financial Analysis
JJ.4 Ratio Analysis
JJ.5 Major Products & Services
KK. Jubilant Life Sciences Ltd
KK.1 Corporate Profile
KK.2 Business Segment Analysis
KK.3 Financial Analysis
KK.4 Ratio Analysis
KK.5 Major Products & Services
LL. Mylan Laboratories Ltd
LL.1 Corporate Profile
LL.2 Business Segment Analysis
LL.3 Financial Analysis
LL.4 Ratio Analysis
LL.5 Major Products & Services
MM. Pharmstandard OJSC
MM.1 Corporate Profile
MM.2 Business Segment Analysis
MM.3 Financial Analysis
MM.4 Ratio Analysis
MM.5 Major Products & Services
NN. Ranbaxy Laboratories
NN.1 Corporate Profile
NN.2 Business Segment Analysis
NN.3 Financial Analysis
NN.4 Ratio Analysis
NN.5 Major Products & Services
OO. Sun Pharmaceutical Industries
OO.1 Corporate Profile
OO.2 Business Segment Analysis
OO.3 Financial Analysis
OO.4 Ratio Analysis
OO.5 Major Products & Services
PP. Taisho Pharmaceutical Co., Ltd.
PP.1 Corporate Profile
PP.2 Business Segment Analysis
PP.3 Financial Analysis
PP.4 Ratio Analysis
PP.5 Major Products & Services
QQ. Chiesi Farmaceutici SpA
RR. Dong-A Pharmaceutical Co. Ltd
SS. Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.
TT. Yunnan Baiyao Group
Section 4: Glossary of Terms
【レポート販売概要】
■ タイトル：世界の製薬産業分析2015■ 英文：Analyzing the Global Pharmaceutical Industry 2015
■ 発行日：2015年2月
■ 調査会社：Aruvian’s R’search
■ 商品コード：ARUV50201
■ 調査対象地域：グローバル
- SwitzerlandのCalcium Carbonate市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Switzerland and its perspectives on the global market for Calcium carbonate. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Calcium carbonate export/import operations in Switzerland. The 2002-2012 period is co …
- 無線周波数成分の世界市場展望2017-20276According to Stratistics MRC, the Global Radio Frequency Component Market is accounted for $15.54 billion in 2017 and is expected to reach $60.02 billion by 2026 growing at a CAGR of 16.2% from 2017 to 2026. Some of the key factors influencing the market growth are growing demand for direct wireless connectivity devices with the internet and advancements in technology and miniaturization property …
- IR分光法（赤外分光法）の世界市場予測（～2022）The IR spectroscopy market is expected to be valued at USD 1.26 Billion by 2022, growing at a CAGR of 6.5% during the forecast period. The major drivers for the growth of the IR spectroscopy market include technological advancements in miniaturization and computerization of IR spectroscopy instruments. The increasing use of IR spectroscopy in the food & beverages industry would foster the growth o …
- 女性用リハビリ製品の世界市場ABSTRACTAbout Women's Health Diagnostics Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have …
- 世界の半導体市場動向（2012-2016）TechNavio's analysts forecast the Global Semiconductor market to grow at a CAGR of 4.07 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of smartphones and tablets. Technological convergence is a trend being witnessed in the Global Semiconductor market. However, the global economic slowdown could pose a challenge to the growth …
- スクリュー圧縮機の世界市場予測（～2021）：種類別（オイルフリー、油冷式）、段別、技術別、需要先別、地域別The global screw compressor market is projected to grow at a CAGR of 6.62% from 2016 to 2021, to reach a market size of USD 11.01 Billion by 2021. This growth is attributed to increasing demand of energy-efficient screw compressors and low maintenance and operation costs. The report segments the screw compressor market on the basis of stage into single-stage and multi-stage. The single-stage segme …
- 世界の艦艇/水上戦闘艦艇市場：競争状況及び戦略的インサイトSummary This report shows the leading Naval Vessels and Surface Combatants market segments in various regions across the world. Details of top companies active across the global Naval Vessels and Surface Combatants market are provided, together with market size and forecast 2013-2023 for the main players across those areas. Key Findings The report provides a detailed analysis of the competitive la …
- 移植の世界市場：組織製品、免疫抑制薬、保存液The global transplantation market is expected to reach USD 51.0 billion by the year 2025, growing at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market. Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major fact …
- 航空IoTの世界市場2017-2021About Aviation IoT IoT is a network of sensors, physical devices, and machines integrated into everyday objects and connected to the Internet for effective data communications. It creates smart communication environments, for example, a smart airport. It also improves the operational efficiency by enhancing the speed of communications in comparison to the existing infrastructure, thereby augmentin …
- 予防ワクチンの世界市場：弱毒生ワクチン、死菌ワクチン、トキソイドワクチン、遺伝子組み換えワクチンAbout Preventable Vaccines Vaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adole …
- 手荷物搬送システムの世界市場：空港クラス、識別技術（バーコード、RFID）、サービス、種類、効率、地域別分析According to the projections in this report, the market size of the baggage handling system market is estimated at USD 6.45 billion in 2015 and is projected to grow at a CAGR of 7.72%, to reach USD 9.36 billion by 2020 during the forecast period. This report provides a comprehensive analysis of the baggage handling system market for the North America, Europe, Asia-Pacific, Middle East, Latin Ameri …
- 研磨剤の世界市場：天然研磨剤、合成研磨剤、砥石車、紙やすり、被覆砥粒、固定砥粒、超砥粒MarketsandMarkets projects that the abrasives market size will grow from USD 41.21 Billion in 2015 to reach USD 58.43 Billion by 2021, at an estimated CAGR of 6.10%. Acquisitions and new product developments are important strategies taken up by many automotive companies in recent years. The abrasives market has been growing in accordance with the global automotive, metal fabrication, and machinery …
- アルツハイマー型認知症治療薬の世界市場予測および分析PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 Summary Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. During the early stages of disease, sleep disturbances and forgetfulness are generally the first presenting symptoms. In the severe stages, patients with AD …
- 化学センサーの世界市場About Chemical Sensors Chemical sensors transfer chemical signals to electrical signals through transducers incorporated in a sensitive layer. They help to analyze the chemical composition of a sample, which is either in a liquid or gaseous form. Chemical sensors consist of a receptor and a transducer, which are controlled by kinetics and thermodynamic chemical reactions and operate in real time. …
- スマートビルディングの世界市場2015-2019About Smart Building A smart building connects BAS with the normal operations of a building such as HVAC, lighting, water supply, and fire emergency. It monitors and controls the energy usage of the building and helps in saving and improving the energy efficiency of the building. The concept of smart building has gained popularity worldwide as home developers have started to realize that these bui …
